Mitsui Chemicals and Chitose Group Launch Novel Open Innovation Initiative to Foster Businesses and Talents

Bringing Together Unique Technologies for Joint Commercialization TOKYO–(BUSINESS WIRE)–Oct. 29, 2018 Mitsui Chemicals, Inc. (TOKYO:4183)(President & CEO: Tsutomu Tannowa) and[…]

Read more

JAMA Publishes Greatly Anticipated Phase III Study Using 22nd Century’s SPECTRUM® Very Low Nicotine Content Cigarettes

Immediate reduction in nicotine content is the clear winner WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–Sep. 05, 2018 22nd Century Group, Inc. (NYSE American:[…]

Read more

Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia

Results showed a significant reduction in transfusion burden compared to placebo Safety profile generally consistent with previously reported data Regulatory[…]

Read more
1 2